Leaderboards/Gastroesophageal reflux and treatments

Gastroesophageal reflux and treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Bridgette K. Martinak
University of Alabama at Birmingham
2
Yeda Wu
QIMR Berghofer Medical Research Institute
3
Thijs Kuipers
Amsterdam University Medical Centers
4
Zihao Bai
Nanjing Children's Hospital
5
Pierfrancesco Visaggi
University of Pisa
6
Eunsol Yang
University of California, San Francisco
7
Kristína Hugová
Institute of Clinical and Experimental Medicine
8
Trevor A. Davis
Washington University in St. Louis
9
John B. Jarman
Stanford University
10
Sepehr Sadafi
Kermanshah University of Medical Sciences

Papers

1
The global, regional, and national patterns of change in the burden of congenital birth defects, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2040
EClinicalMedicine|2024
252 cit.
2
The global, regional, and national patterns of change in the burden of nonmalignant upper gastrointestinal diseases from 1990 to 2019 and the forecast for the next decade
International Journal of Surgery|2024
96 cit.
3
Publication in BMC Gastroenterology (2024) [49 citations, W4391535892]
BMC Gastroenterology|2024
49 cit.
4
Publication in Psychopharmacology Bulletin (2025) [43 citations, W2981820140]
Psychopharmacology Bulletin|2025
43 cit.
5
Publication in Journal of Neurogastroenterology and Motility (2024) [39 citations, W4390595162]
Journal of Neurogastroenterology and Motility|2024
39 cit.
6
Publication in Communications Biology (2025) [24 citations, W4411575859]
Communications Biology|2025
24 cit.
7
Adaptive Behaviors, Esophageal Anxiety, and Hypervigilance Modify the Association Between Dysphagia Perception and Histological Disease Activity in Eosinophilic Esophagitis
The American Journal of Gastroenterology|2024
22 cit.
8
Focal Distal Esophageal Dilation (Blown-Out Myotomy) After Achalasia Treatment: Prevalence and Associated Symptoms
The American Journal of Gastroenterology|2024
19 cit.
9
Multiomics integration and machine learning reveal prognostic programmed cell death signatures in gastric cancer
Scientific Reports|2024
19 cit.
10
Epidemiology, Natural History, and Treatment of Eosinophilic Gastrointestinal Diseases
Gastroenterology|2025
16 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Britta Haenisch
Federal Institute for Drugs and Medical Devices
2
Rui Wang
King's College London
3
Jim Melberg
Sheba Medical Center
4
Ezra N. Teitelbaum
Northwestern University
5
D. E. Rumyantseva
Sechenov University
6
Yuzo Kodama
Kobe University
7
Joanne Boag
Walter and Eliza Hall Institute of Medical Research
8
Praveen K. Potukuchi
Morristown Medical Center
9
Tanya Irvine
Flinders University
10
Robert P. Wilfahrt
Mayo Clinic in Arizona

Papers

1
Global, regional and national burden of gastroesophageal reflux disease, 1990–2019: update from the GBD 2019 study
Annals of Medicine|2022
254 cit.
2
World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics
Journal of Clinical Gastroenterology|2024
181 cit.
3
Helicobacter pylori World Gastroenterology Organization Global Guideline
Journal of Clinical Gastroenterology|2022
178 cit.
4
Global, regional, and national burden of 10 digestive diseases in 204 countries and territories from 1990 to 2019
Frontiers in Public Health|2023
95 cit.
5
Functionalization of soy residue (okara) by enzymatic hydrolysis and LAB fermentation for B2 bio-enrichment and improved in vitro digestion
Food Chemistry|2022
42 cit.
6
The impact of using ChatGPT on academic writing among medical undergraduates
Annals of Medicine|2024
28 cit.
7
Effect of mussel polysaccharide on glucolipid metabolism and intestinal flora in type 2 diabetic mice
Journal of the Science of Food and Agriculture|2023
18 cit.
8
Digestive Tract Tuberculosis Guideline
Journal of Clinical Gastroenterology|2023
15 cit.
9
The importance of pH adjustment for preventing fibrin glue dissolution in the stomach: an in vitro study
Scientific Reports|2022
13 cit.
10
Feasibility and safety of endoscopic submucosal dissection for lesions in proximity to a colonic diverticulum
Clinical Endoscopy|2022
13 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Donald O. Castell
Pennsylvania Hospital
2
Peter J. Kahrilas
Northwestern University
3
Joel E. Richter
Cleveland Clinic
4
Tom R. DeMeester
University of Southern California
5
John E. Pandolfino
Northwestern University
6
Daniel Sifrim
Queen Mary University of London
7
Richard W. McCallum
Texas Tech University
8
Ronnie Fass
University of Arizona
9
Michael F. Vaezi
Vanderbilt University Medical Center
10
Jan Tack
KU Leuven

Papers

1
The Chicago Classification of esophageal motility disorders, v3.0
Neurogastroenterology & Motility|2014
2k cit.
2
Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease
The American Journal of Gastroenterology|2005
1.1k cit.
3
Role of impaired gastric accommodation to a meal in functional dyspepsia
Gastroenterology|1998
1.1k cit.
4
Symptomatic gastroesophageal reflux: Incidence and precipitating factors
Digestive Diseases and Sciences|1976
884 cit.
5
Nissen Fundoplication for Gastroesophageal Reflux Disease
Annals of Surgery|1986
870 cit.
6
Achalasia: A New Clinically Relevant Classification by High-Resolution Manometry
Gastroenterology|2008
809 cit.
7
Patterns of Gastroesophageal Reflux in Health and Disease
Annals of Surgery|1976
729 cit.
8
ACG Clinical Guideline: Diagnosis and Management of Achalasia
The American Journal of Gastroenterology|2013
722 cit.
9
American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease
Gastroenterology|2008
699 cit.
10
Esophageal peristaltic dysfunction in peptic esophagitis
Gastroenterology|1986
667 cit.

Reagents for Gastroesophageal reflux and treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Agilent/Dako

Mast Cell Tryptase

#M7052
View Evidence →
Cell Signaling TechnologyEvidence 66

beta2-Adrenergic Receptor (D6H2) Rabbit Monoclonal Antibody

#8513$161,351
View Evidence →
Cell Signaling TechnologyEvidence 64

MAVS (E8Z7M) Rabbit Monoclonal Antibody (BSA and Azide Free)

#98156$865
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

Anti-Serotonin

#M0758
View Evidence →
Cell Signaling TechnologyEvidence 60

MT-ND3 (E8O4E) Rabbit Monoclonal Antibody

#82933$161,351
View Evidence →
Cell Signaling TechnologyEvidence 64

ALCAM (F3V8Q) Rabbit Monoclonal Antibody

#10623$161,376
View Evidence →